When medical professionals aren't trained on bleeding disorders, patients face critical delays in treatment, says columnist.

Malia Hall, 7, suffered a stroke at birth due to a rare bleeding disorder called Neonatal Alloimmune Thrombocytopenia, or NAIT.

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Hurricane preparedness can involve some extra considerations for those with hemophilia, says columnist Jennifer Lynne, who shares some tips.

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, the U.S. drugmaker said on Thursday.

COPENHAGEN, Denmark and CAMBRIDGE, Mass., June 24, 2025 /PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved ...

Hemab Therapeutics Presents Positive Clinical and Preclinical Data Across Bleeding Disorder Pipeline at ISTH 2025 Congress PR Newswire COPENHAGEN, Denmark and CAMBRIDGE, Mass., June 24, 2025 ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's Research Hospital and University College London ...

Noncancerous blood disorders include clotting disorders, bleeding disorders, various forms of anemia, and eosinophilic disorders.

Mild clotting disorders often reveal themselves first through frequent nosebleeds before more serious bleeding complications develop elsewhere in the body.